Economic evaluation of NT-proBNP for heart failure risk assessment in patients with type 2 diabetes in China
NT-proBNP is a dominant and robust cost-saving strategy for HF risk assessment in patients with T2DM in China, reducing both HF cases and associated healthcare costs.
Authors
- Miao Yu (ORCID: https://orcid.org/0000-0002-5945-7430)
- Jianwei Xuan
- Powei Wu
- Xinguo Hou
- Junping Wen
- Zhiwei Leng
- Chaogui Tang
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Huaian First People’s Hospital (CN)
- Fujian Provincial Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1016/j.diabres.2025.113068
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00